Cargando…
Molecular target based combinational therapeutic approaches in thyroid cancer
BACKGROUND: Thyroid cancer, as with other types of cancer, is dependent on angiogenesis for its continued growth and development. Interestingly, estrogen has been shown to contribute to thyroid cancer aggressiveness in vitro, which is in full support of the observed increased incidence of thyroid ca...
Autores principales: | Rajoria, Shilpi, Suriano, Robert, George, Andrea L, Kamat, Ameet, Schantz, Stimson P, Geliebter, Jan, Tiwari, Raj K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418191/ https://www.ncbi.nlm.nih.gov/pubmed/22548798 http://dx.doi.org/10.1186/1479-5876-10-81 |
Ejemplares similares
-
Estrogen Induced Metastatic Modulators MMP-2 and MMP-9 Are Targets of 3,3′-Diindolylmethane in Thyroid Cancer
por: Rajoria, Shilpi, et al.
Publicado: (2011) -
Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines
por: Suriano, Robert, et al.
Publicado: (2013) -
Disruption of mutated BRAF signaling modulates thyroid cancer phenotype
por: Hanly, Elyse K, et al.
Publicado: (2014) -
PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells
por: George, Andrea L., et al.
Publicado: (2015) -
Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence
por: George, Andrea L, et al.
Publicado: (2012)